breast cancer and glp 1 drugs New study examines GLP-1 a reduction in risk https://www.goodmorningamerica.com/news/story Researchers from Penn Medicine found

NH2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1: implications in Alzheimers disease

Conversely, abnormal blood glucose levels have been shown to elevate cancer risk and decrease survival rates in cancer patients [12, 50]

Note: This article offers general information and does not replace professional medical advice

They include: Reaction at injection site Digestive effects (like nausea, vomiting, diarrhea, or constipation) Dizziness Fatigue Hair loss Change in taste Some serious side effects may occur in patients taking either of these drugs

[DOI] [PubMed] [Google Scholar] 28.Baig K, Dusetzina SB, Kim DD, Leech AA

Additionally, there were more deaths in the Tirzepatide group than semaglutide (12 vs 1)